{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:58:24Z","timestamp":1779119904551,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.09.041","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T12:32:14Z","timestamp":1191933134000},"page":"8114-8122","source":"Crossref","is-referenced-by-count":59,"title":["Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety"],"prefix":"10.1016","volume":"25","author":[{"given":"Jeffrey M.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim T.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.09.041_bib1","first-page":"301","article-title":"Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs\u2014worldwide, 2000\u20132004","volume":"55","author":"Anonymous","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2007.09.041_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.09.041_bib3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2007.09.041_bib4","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.041_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.09.041_bib6","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.09.041_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2014different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.041_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.041_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0197-2456(94)90042-6","article-title":"Field trials of tuberculosis vaccines: how could we have done them better?","volume":"15","author":"Comstock","year":"1994","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2007.09.041_bib10","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/IAI.73.4.2190-2196.2005","article-title":"Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens","volume":"73","author":"Demangel","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.041_bib11","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.09.041_bib12","first-page":"93","article-title":"Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety","volume":"68","author":"Milstien","year":"1990","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2007.09.041_bib13","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.09.041_bib14","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.09.041_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/clinids\/20.1.126","article-title":"Relationship between bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis","volume":"20","author":"Brewer","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.041_bib16","first-page":"18","article-title":"Global Advisory Committee on Vaccine Safety, 29\u201330 November 2006","volume":"82","author":"Anonymous","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2007.09.041_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm0307-286","article-title":"Mycobacterial virulence and specialized secretion: same story, different ending","volume":"13","author":"Behr","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.09.041_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.09.041_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.64.1.1-9.1996","article-title":"Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains","volume":"64","author":"Lagranderie","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.041_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0041-3879(88)90051-7","article-title":"The protective and allergenic potency of four BCG substrains in use in China determined in two animal models","volume":"69","author":"Wang","year":"1988","journal-title":"Tubercle"},{"key":"10.1016\/j.vaccine.2007.09.041_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/47042","article-title":"Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice","volume":"402","author":"Cox","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.09.041_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature02837","article-title":"A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response","volume":"431","author":"Reed","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.09.041_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1365-2958.2007.05603.x","article-title":"Identification of the lipooligosaccharide biosynthetic gene cluster from Mycobacterium marinum","volume":"63","author":"Ren","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tube.2006.05.003","article-title":"Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities","volume":"87","author":"Jackson","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2007.09.041_bib25","first-page":"27","article-title":"BCG vaccine. WHO position paper","volume":"79","author":"Anonymous","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2007.09.041_bib26","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JB.187.7.2267-2277.2005","article-title":"Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG","volume":"187","author":"Hotter","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.plipres.2005.07.001","article-title":"The dimycocerosate ester polyketide virulence factors of mycobacteria","volume":"44","author":"Onwueme","year":"2005","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.vaccine.2007.09.041_bib28","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1128\/JB.01212-06","article-title":"Mycobacterium tuberculosis SigM positively regulates Esx secreted protein and nonribosomal peptide synthetase genes and down regulates virulence-associated surface lipid synthesis","volume":"188","author":"Raman","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib29","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1099\/mic.0.28993-0","article-title":"Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress","volume":"152","author":"Sirakova","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2007.09.041_bib30","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0264-410X(00)00369-8","article-title":"Identification of substrains of BCG vaccine using multiplex PCR","volume":"19","author":"Bedwell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.041_bib31","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.vaccine.2006.03.055","article-title":"Identification of two subpopulations of Bacillus Calmette-Guerin (BCG) Tokyo172 substrain with different RD16 regions","volume":"24","author":"Honda","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.041_bib32","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.chembiol.2004.04.015","article-title":"Characterization and investigation of substrate specificity of the sugar aminotransferase WecE from E. coli K12","volume":"11","author":"Hwang","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1462-5822.2004.00368.x","article-title":"Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection","volume":"6","author":"Rousseau","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2958.1999.01593.x","article-title":"Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis","volume":"34","author":"Camacho","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib35","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1128\/JB.01670-06","article-title":"The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated","volume":"189","author":"Reed","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib36","first-page":"107","article-title":"BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv Tuberc Res"},{"key":"10.1016\/j.vaccine.2007.09.041_bib37","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/j.vaccine.2004.01.050","article-title":"Report on a WHO consultation on the characterisation of BCG strains, Imperial College, London 15\u201316 December 2003","volume":"22","author":"Corbel","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.041_bib38","first-page":"52","article-title":"Reduction in the risk of tuberculous meningitis in children in France. Impact of BCG vaccination","volume":"63","author":"Lotte","year":"1988","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2007.09.041_bib39","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.vaccine.2004.07.052","article-title":"BCG vaccine-associated suppurative lymphadenitis","volume":"23","author":"Teo","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.041_bib40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.63.2.672-675.1995","article-title":"Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination","volume":"63","author":"Ulstrup","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.09.041_bib41","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1365-2958.2005.04618.x","article-title":"Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK","volume":"56","author":"Charlet","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijid.2004.05.008","article-title":"Epstein-Barr virus associated with primary CNS lymphoma and disseminated BCG infection in a child with AIDS","volume":"9","author":"Fallo","year":"2005","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.041_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.041_bib44","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1086\/378298","article-title":"Danish bacille Calmette-Guerin vaccine-induced disease in human immunodeficiency virus-infected children","volume":"37","author":"Hesseling","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.09.041_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2007.09.041_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/CMR.18.4.687-702.2005","article-title":"Vaccines for tuberculosis: novel concepts and recent progress","volume":"18","author":"Doherty","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2007.09.041_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/38151","article-title":"Has BCG attenuated to impotence?","volume":"389","author":"Behr","year":"1997","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T10:41:29Z","timestamp":1684060889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07010778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":47,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07010778"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}